Orlando Medisystems Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 53.00 Cr
- Revenue Growth 10.94%
- Profit Growth 28.22%
- Ebitda 58.71%
- Net Worth 14.04%
- Total Assets 16.55%
About Orlando Medisystems
Orlando Medisystems Private Limited (OMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 August 2010 and has a history of 14 years and six months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹53.00 Cr.
Ujwal Kanoi and Pooja Kanoi serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232DL2010PTC206588
- Company No.
206588
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Aug 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Orlando Medisystems?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ujwal Kanoi  | Director | 03-Aug-2010 | Current |
| Pooja Kanoi | Director | 03-Aug-2010 | Current |
Financial Performance of Orlando Medisystems.
Orlando Medisystems Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.94% increase. The company also saw a substantial improvement in profitability, with a 28.22% increase in profit. The company's net worth Soared by an impressive increase of 14.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orlando Medisystems?
In 2023, Orlando Medisystems had a promoter holding of 100.00%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Linear Infracon Private LimitedUjwal Kanoi is a mutual person
- Arpan Technologies Private Limited
Ujwal Kanoi and Pooja Kanoi are mutual person
- Moka Estates Private Limited
Pooja Kanoi is a mutual person
Charges (Loans)
₹530.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 53.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2022 | Hdfc Bank Limited | ₹53.00 Cr | Open |
How Many Employees Work at Orlando Medisystems?
Unlock and access historical data on people associated with Orlando Medisystems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orlando Medisystems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orlando Medisystems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.